BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22994703)

  • 21. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
    Matthews C; Catherwood MA; Morris TC; Kettle PJ; Drake MB; Gilmore WS; Alexander HD
    Eur J Haematol; 2006 Oct; 77(4):309-17. PubMed ID: 16856923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
    Hallek M; Emmerich B; Strohmeyer S; Busch R; Reichle A; Senekowitsch R
    Klin Wochenschr; 1988 Aug; 66(16):718-23. PubMed ID: 3172680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
    Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
    Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia.
    Matuszak M; Lewandowski K; Czyż A; Kiernicka-Parulska J; Przybyłowicz-Chalecka A; Jarmuż-Szymczak M; Lewandowska M; Komarnicki M
    Leuk Res; 2016 Aug; 47():166-71. PubMed ID: 27376546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Importance of prognostic factors in patients with chronic B-lymphocytic leukemia at the time of diagnosis].
    Cmunt E; Michalová K; Sindelárová L; Karban J; Zemanová Z; Kurková S; Brezinová J; Schwarz J; Bosáková Z
    Sb Lek; 2002; 103(3):359-70. PubMed ID: 12688180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
    Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
    Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of four prognostic scoring system in patients with early asymptomatic chronic lymphocytic leukemia patients].
    Sha YQ; Shen H; Wu W; Xia Y; Miao Y; Cao L; Wang L; Fan L; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):834-839. PubMed ID: 34788923
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and biological features of 8 patients with Richter's syndrome].
    Zhu HY; Xu W; Miao KR; Hong M; Fang C; Zhu DX; Wu YJ; Qiao C; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1499-504. PubMed ID: 21176359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absolute lymphocyte count with extreme hyperleukocytosis does not have a prognostic impact in chronic lymphocytic leukemia.
    Shvidel L; Bairey O; Tadmor T; Braester A; Ruchlemer R; Fineman R; Joffe E; Berrebi A; Polliack A;
    Anticancer Res; 2015 May; 35(5):2861-6. PubMed ID: 25964568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia.
    Leotard S; Chastang C; Travade P; Jaudon MC; Tournilhac O; Baudet S; Merle-Beral H
    Hematol J; 2000; 1(5):301-6. PubMed ID: 11920207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Factors for Chronic Lymphocytic Leukemia.
    Chen C; Puvvada S
    Curr Hematol Malig Rep; 2016 Feb; 11(1):37-42. PubMed ID: 26748932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia.
    Vener C; Gianelli U; Cortelezzi A; Fracchiolla NS; Somalvico F; Savi F; Pasquini MC; Bosari S; Deliliers GL
    Leuk Lymphoma; 2006 Feb; 47(2):245-51. PubMed ID: 16321853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
    Ravandi-Kashani F; O'Brien S; Manshouri T; Lerner S; Sim S; Dodd K; Kantarjian H; Freireich E; Keating M; Albitar M
    Leuk Res; 2000 Jun; 24(6):469-74. PubMed ID: 10781679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
    Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.